Early adversity, in the form of abuse, neglect, socioeconomic status and other adverse experiences, is associated with poor physical and mental health outcomes. To understand the biologic mechanisms underlying these associations, studies have evaluated the relationship between early adversity and telomere length, a marker of cellular senescence. Such results have varied in regard to the size and significance of this relationship. Using meta-analytic techniques, we aimed to clarify the relationship between early adversity and telomere length while exploring factors affecting the association, including adversity type, timing and study design. A comprehensive search in July 2016 of PubMed/MEDLINE, PsycINFO and Web of Science identified 2462 studies. Multiple reviewers appraised studies for inclusion or exclusion using a priori criteria; 3.9% met inclusion criteria. Data were extracted into a structured form; the Newcastle-Ottawa Scale assessed study quality, validity and bias. Forty-one studies (N = 30 773) met inclusion criteria. Early adversity and telomere length were significantly associated (Cohen's d effect size = − 0.35; 95% CI, -0.46 to -0.24; P o 0.0001). Sensitivity analyses revealed no outlier effects. Adversity type and timing significantly impacted the association with telomere length (P o 0.0001 and P = 0.0025, respectively). Subgroup and meta-regression analyses revealed that medication use, medical or psychiatric conditions, case-control vs longitudinal study design, methodological factors, age and smoking significantly affected the relationship. Comprehensive evaluations of adversity demonstrated more extensive telomere length changes. These results suggest that early adversity may have long-lasting physiological consequences contributing to disease risk and biological aging.
INTRODUCTION
Early life adversity is a major public health problem experienced by over 19.4 million children.
1, 2 Children with a history of early adversity are at a greater risk of developing poor physical and mental health outcomes, including diabetes, asthma, depression, anxiety and post-traumatic stress disorders. [3] [4] [5] These conditions are often chronic and severe, exacting costs in excess of $124 billion through suffering, disability, treatment and loss of productivity over the lifespan. 6 Investigation into the biologic mechanisms by which early adversity increases risk for poor health outcomes provides evidence of accelerated biologic aging through shortened telomere length. [7] [8] [9] Telomeres are DNA-protein complexes comprising tandem TTAGGG repeats ranging from a few to 15 kilobases in length that are essential for maintaining chromosomal and genetic stability. 10 Telomeres shorten with each DNA replication cycle and, as such, telomere length serves as a biomarker of biological aging. 11 When telomeres become critically short, cells may enter senescence or undergo apoptosis. 9, 12 Telomere length is influenced by stress and inflammation. 9 Many chronic illnesses involve prolonged states of stress and/or inflammation, which may contribute to associations between telomere length and somatic conditions, including heart disease, diabetes, asthma, obesity, chronic pain, irritable bowel syndrome and neurodegenerative disorders. 11, [13] [14] [15] [16] Proposed mechanisms underlying associations between stress and telomere length include mitochondrial dysfunction and telomerase inactivation due to heightened and prolonged stress signaling. 9, 17, 18 In addition to reflecting biologic stress, telomere attrition often precedes chronic disease development, suggesting that telomere erosion may be a causal link connecting early adversity and later disease. 12 Telomere attrition early in life may be particularly detrimental, 19 leading to premature development of stress-related health disorders. 9, 12 Less than a decade ago, preliminary evidence suggested that childhood adversity was associated with telomere shortening. 20 Since then, numerous studies have examined associations between early adversity and telomere length. 9, 14 Shortened telomeres have been linked to adversity at multiple developmental stages 18, [21] [22] [23] and after several types of adverse exposures. [24] [25] [26] Some investigations suggest a cumulative and dose-dependent negative relationship between early adversity and telomere length. 27, 28 However, numerous studies have not observed shorter telomeres after early adversity. [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] Several issues arise when assessing the existing body of knowledge relating telomeres and early adversity. Most studies have modest sample sizes, limiting the ability to draw definitive conclusions. Additionally, variability in study design, methodology, subject characteristics, early adversity type and developmental timing limits the generalizability of available data. This meta-analysis aims to clarify the relationship between early adversity and telomere length by means of a systematic examination of the literature, comparing subjects with early adversity exposure to those without, and to identify moderators of the association with telomere length. We hypothesized that early adversity would be associated with reduced telomere length, and that this relationship would be modified by study and subject characteristics. 
MATERIALS AND METHODS

Protocol and registration
A protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO, CRD42016035239). This study was designed, executed and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement 44 and the Cochrane reporting items for meta-analyses. 45 The Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Guidelines 46 were also followed and adapted into PRISMA.
Study eligibility
Included studies: (1) examined the effects of early adversity in the form of abuse, neglect, socioeconomic status (SES) or other adverse exposures on human subjects occurring prenatally up to age 18; (2) provided adequate description of adversity assessments; and (3) presented sufficient data to calculate effect sizes. Prospective, observational and retrospective studies were considered. Studies using indirect proxies of early adversity, such as parental education alone, were excluded. When two manuscripts presented results from non-independent data sets, the manuscript with the larger number of subjects was included.
Information sources and search strategy
A comprehensive electronic search in July 2016 identified English language studies indexed in PubMed/Medline, PsycINFO and Web of Science; no publication date limitations were set. The search was performed by investigators with topic clinical and research experience (ML and KKR) in consultation with a librarian trained in systematic reviews. Investigators reviewed titles, abstracts and articles; disagreements were settled by consensus. The search strategy included terms and combinations to identify early adversity and telomeres: 'child neglect', placenta, antenatal, prenatal, trauma, poverty, 'child abuse', 'socioeconomic status', 'childhood maltreatment', 'parental loss', environment, neighborhood, abuse, maltreatment, adversity, 'early life stress', telomerase, telomeres, telomere, telo* (Supplementary Table S1 ). Primary study and review article references were searched; studies were appraised for inclusion or exclusion using a priori criteria as described under study eligibility.
Data extraction
Data were extracted independently (ML, LG and KKR) using a structured form. Extractors were not blinded to study results, authors or institutions; inter-rater reliability was high (497%). Conflicts regarding data extraction were resolved by consensus with another reviewer (SJR). Data extraction variables are listed in Table 1 . When provided, data fully adjusted for potential covariates were abstracted rather than partially adjusted or unadjusted values. Study quality was assessed using Cochrane Review 45 and Agency for Healthcare Research and Quality 47 guidelines. The Newcastle-Ottawa Scales (NOS) for cross-sectional, case-control or cohort designs 48 were used to assess risk of bias for all studies (LG); blinded replications of these assessments had good reproducibility (97%; ML).
When studies did not report an overall effect but instead included data on various types of adversity exposures in the same group of subjects, 31, [33] [34] [35] 42, 43, 49 data were converted to SMs (SMDs) and pooled to allow comparison of a grouped early adversity value in the main metaanalysis, 50 unless the adversity grouping was not limited to early life. 36 When studies presented more than one independent data set by one of the subgroups examined in this study (e.g., adversity type, medical/ psychiatric condition), these were treated as separate data sets represented by the first author's last name, publication date and alpha character. 32, 34, 39, 40, 51, 52 Statistical analysis Data were converted into SMDs using the effect size calculator 53 and reported as Cohen's d. 54 The SMD is the mean difference in telomere length between the early adversity-exposed and non-exposed groups divided by the pooled standard deviation, resulting in a unitless effect size measure comparable between studies. By convention, effect sizes of 0.2, 0.5 and 0.8 are small, medium and large, respectively. 54 If correlations (r) or odds ratios (OR) were reported, they were converted to Cohen 
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Analyses were performed using Comprehensive Meta-Analysis Software (V2.2.064 Biostat, Englewood, NJ, USA). Heterogeneity was calculated using the I 2 statistic, which provides a measure of the variance attributable to between-study differences 55 (0% = none, 25% = low, 50% = moderate and 75% = high heterogeneity). A random effects model was utilized after initial fixed effects model analyses revealed high inter-study heterogeneity (I 2 = 74%). Confidence intervals (CI; 95%) and P-values (α = 0.05) were calculated. Sensitivity analyses were performed utilizing the 'leave-one-out' strategy. 56 Publication bias was assessed with Egger's regression intercept. 57 Duval and Tweedie's trim and fill analysis 58 on both sides of the mean calculated effect size estimates accounting for reporting bias.
Moderator analyses
Meta-regression and subgroup moderator analyses were performed to examine potential sources of inter-study heterogeneity. The Benjamini and Hochberg 59 method was used to control for multiple comparisons, with a false discovery rate set to 0.05. Method of moments random effects metaregression 50 was used for the moderators of mean age, percent cigarette users, percent females, NOS score, developmental exposure period and time since exposure. Developmental stages were defined using the Center for Disease Control (CDC) definitions 60 and neurodevelopmental data; 61 CDC stages were further collapsed to ensure a sufficient number of studies (k) for each grouping while maintaining developmental relevance. Groupings were: early development (prenatal-4 years; k = 7), childhood (up to 12 years; k = 10) and adolescence (up to 18 years; k = 23); one study did not provide assessment age. 42 Time since exposure was defined as mean study population age minus the maximal age at adversity exposure.
Subgroups. For categorical moderators, subgroup analyses were conducted using a continuous random effects model. 62 Subgroups were delineated using the following criteria: Medical condition (some or all subjects had a current chronic medical condition; 32, 33, 36, 37, 49, 63, 64 ,65 k = 8), psychiatric condition (some or all subjects had a current 27, 28, 30, 39, 40, 49, 63, 66, 67 or current and/or past 36,43,52,64 psychiatric condition; k = 14), and medication use (some or all subjects were taking medication at the time of telomere measurement tissue collection; [30] [31] [32] 39 ,63 k = 5). Only studies specifying participant conditions and medication use were included in this subgroup analysis.
Telomere measurement technique. k = 36 studies examined the ratio of telomere repeat copy numbers to single-copy gene numbers (T/S ratio) using quantitative real-time PCR (qPCR). Two studies utilized Southern blot, 31, 42 one study used terminal restriction fragment (TRF) analysis 68 and one study with two data sets used low-coverage whole-genome sequencing. 39 We compared qPCR to all other telomere measurement techniques.
Source tissue. Telomere measurement source tissues were: leukocyte (k = 31; included one study of lymphocytes), buccal cells (k = 4), saliva (k = 4) and cord blood (k = 2).
Study design. Study design was grouped as case-control (k = 12), cross-sectional (k = 25) and prospective (k = 4).
Early adversity type and comprehensiveness of assessment. We wanted to examine whether the comprehensiveness of adversity assessment impacted the relationship between telomeres and early adversity. As such, studies were grouped according to whether they narrowly assessed one or two forms of abuse (emotional, physical, sexual or verbal abuse; k = 6), assessed all forms of abuse and neglect (k = 8), or assessed all forms of abuse, neglect and other forms of adversity (k = 4). We also examined assessments of SES (k = 8) and maternal depression (k = 2). A broad category of other adversity (including child welfare involvement, nonsupportive/conflict-driven parenting, institutionalization, family instability, domestic violence, psychosocial stress, bullying, divorce, parental separation, serious illness or neighborhood disorder; k = 17) was created to include assessments of exposures not already categorized. For manuscripts assessing more than one type of adversity and presenting data on telomere length related to that adversity, effect sizes were calculated for each type and included in the appropriate subgroup. Supplementary Table S2 contains study descriptions of adversity assessment and resulting categorizations.
RESULTS
After initial search and screening, 95 studies were assessed for eligibility. Thirty-four studies with 41 independent data sets met full inclusion criteria (N = 30 773; Figure 1 ). The cumulative average age at time of telomere measurement was 31 ± 22 years; 60 ± 25% were female. Thirty-eight percent of studies assessed other adversities, 18% abuse and neglect, 18% SES, 13% abuse, 9% abuse, neglect and other adversities and 4% maternal depression.
The overall association between early life adversity (k = 41) and telomere length as Cohen's d was − 0.35 ( Figure 2 ; 95% CI, -0.46 to -0.24, P o 0.0001). Sensitivity analyses did not alter the overall Cohen's d, suggesting the results were not driven by a single study. Egger's regression suggested funnel plot asymmetry (Supplementary Figure S1 ; B = − 2.04, 95% CI, − 3.22 to − 0.87, t = 3.51, P = 0.001), suggesting reporting bias and/or heterogeneity between studies. 69 Heterogeneity was detected in the primary meta-analysis (I 2 = 42%); moderator analyses were performed to examine significant sources of this heterogeneity.
Type of early life adversity, developmental timing and telomere measurement Moderator analysis by type of early adversity revealed a significant difference between groups (P o 0.0001; Figure 3a) . Studies with comprehensive adversity assessments (abuse, neglect and other adversities, d = − 0.711) had negative effect sizes of greater magnitude than those with narrow adversity assessments (abuse and neglect or narrow focus on abuse; d = − 0.13 and − 0.055, respectively). Meta-regression of Cohen's d vs developmental stage of adversity exposure revealed adversity in earlier developmental periods showed greater telomere shortening (B = 0.216, 95% CI, 0.076-0.356, P = 0.0025, R 2 = 0.18; Figure 4a ). Increased temporal proximity to adversity exposure was also associated with shorter telomere length (B = 0.011, 95% CI 0.0045 to 0.0017, P = 0.0007, R 2 = 0.10; Figure 4b ). Medical or psychiatric conditions, medication use and demographics Moderator analysis of studies including medical conditions vs no medical condition and psychiatric conditions vs no psychiatric condition were significant (Po 0.0001 for both). Studies with no medical or psychiatric conditions had negative effect sizes of greater magnitude than those with medical and psychiatric conditions, respectively (Figure 3b) . Similarly, moderator analysis of participant medication use was significant (P o 0.0001), with studies containing no participants on medications showing a negative Cohen's d of greater magnitude (Figure 3b ).
Larger negative effects were seen in studies with younger participants (B = 0.010, 95%, CI 0.0049-0.0153, P o 0.0001, R 2 = 0.19), and with less cigarette users (B = 0.009, 95% CI, 0.0005-0.0174, P = 0.038, R 2 = 0.16). The relationship between percent female subjects and Cohen's d was not significant (P = 0.098).
Telomere measurement technique Studies grouped by the telomere measurement technique were significantly different (P o 0.0001; Figure 3c) , with studies utilizing Figure 2 . Forest plot of effect sizes reported as Cohen's d (x-axis) evaluating early life adversity and telomere length using the random effects model. Points represent effect size; lines represent 95% confidence intervals (CI). Diamond indicates overall effect size and 95% CI.
qPCR showing a significant and larger effect size (P o 0.0001). Studies utilizing other techniques also revealed a significant, negative effect size (P = 0.024).
Source tissue was a significant moderator of effect size (P o 0.0001; Figure 3c ). Studies using leukocyte, buccal or saliva cells showed a significant effect size (P o 0.0001, o0.0001 and 0.029, respectively). Although the cord blood group Cohen's d was largest in magnitude, it was not a significant grouping (P 40.05).
Study design significantly moderated the relationship between early adversity and telomere length (P o 0.0001; Figure 3c ). Crosssectional and case-control studies showed significant Cohen's d (Po 0.0001 for both), but the effect size of the small number of prospective studies was not significant (P40.05). Risk of bias as determined by NOS score was not significantly associated with Cohen's d (P40.05). All reported significant overall subgroup and regression analyses survived Benjamini-Hochberg correction for false discovery rate.
DISCUSSION
This meta-analysis supports an association between reduced telomere length and early life adversity. Using Cohen's categorization, 54 the overall effect is between small to medium. Moderators can affect the relationship between telomere length and early adversity and reveal variables that have an additive or opposing effect. The Cohen's d effect size magnitude was medium to large in some moderator analyses, including type of adversity, comorbidities, and medication use. Trim and fill analysis indicated asymmetry in the funnel plot. Cumulative effects analysis revealed the effect size approached that estimated by trim and fill analysis with the addition of the top six to seven weighted studies (data not shown), suggesting asymmetry due to heterogeneity between studies. 69 Our results help explain the existing literature, which includes mixed findings concerning the relationship between early adversity and telomeres.
The developmental timing of adversity exposure significantly influenced the effect size, with adversity earlier in development showing greater negative effects. This finding suggests that exposure to early adversity may impact a child's developmental trajectory and health. Our finding that the magnitude of the negative association between early adversity and telomere length decreased with increasing years since exposure suggests that telomere shortening might be reversible over time, underscoring the fact that additional life experiences contribute to overall health. In our review of the literature on telomeres and early adversity, there were little data regarding consistency of care providers, nurturing relationships and other resilience-associated factors. 70 To better understand the impact of all exposures, future studies would benefit from a comprehensive examination of both adversity and resilience factors.
The heterogeneity and magnitude of effect detected between early adversity and telomere length varied by the type of adversity exposure. Studies comprehensively assessing adversity, such as those examining abuse, neglect and other adversities, revealed a negative Cohen's d of greater magnitude than studies narrowly assessing only abuse. The abuse subgrouping was nonsignificant (P = 0.26), which may reflect undetected effects of neglect and other adversities occurring in both the abuse and comparison groups missed by the narrow assessment. The effect for the maternal depression grouping was large (d = − 1.34), but included two studies with a total of 300 subjects. These two studies did not assess the influence of maternal depression on child experience; as such this finding warrants further investigation. Studies of SES reached significance (P = 0.017) with a small effect size. Only one SES study 26 assessed SES as related to emotional stress; 64 future investigations of environmental adversity and stress perception rather than SES alone may provide novel insights.
Mechanisms underlying early adversity and telomere length associations are largely unknown. 14, 25 Telomeres shorten after repeated cellular divisions and cellular stress exposures. 71 It has been speculated that early adversity directly activates or is associated with increased cellular stress and replication, resulting in accelerated telomere shortening. 8, 17 Telomerase activity, a key regulator of telomere length, is decreased with adversity exposure. 72 Telomere repair and lengthening strategies vary depending on the developmental phase of the cell; 73 it is possible these strategies are differentially responsive to adversity and may explain the relationship between developmental stage at adversity and impact on telomere length.
Previous meta-analyses reported a negative relationship between psychiatric disorders and telomere length. 74, 75 In this analysis, the Cohen's d for studies including subjects with psychiatric disorders was of smaller magnitude than studies excluding psychiatric disorders. This finding likely reflects inclusion of subjects with psychiatric disorders in both the early stress cases and controls, confounding the ability to detect telomere shortening due to early stress alone. The inter-study heterogeneity was greater for the groups with psychiatric conditions compared with those without (I 2 = 58% vs 0%), further suggesting that the relationship between psychiatric conditions and telomere length may confound the relationship between early adversity and telomeres. The analysis of medical conditions yielded similar results. Grouping studies based on subject medication use also impacted the magnitude of the relationship between early adversity and telomere length. This may reflect the underlying medical or psychiatric comorbidities or a direct effect of medication on telomere length.
The telomere measurement technique, source tissue and study design all significantly moderated the association between early adversity and telomere length. qPCR showed a slightly larger Cohen's d than other techniques combined, although both groupings were significant. As the effect size for studies using qPCR was in the same direction and of similar magnitude to both the overall effect size and other telomere measurement techniques, and given the comparable ease of qPCR compared with some telomere measurement techniques such as Southern blot, these results support the use of qPCR as a valid technique. Studies using leukocytes, buccal cells and saliva all had significant relationships between early adversity and telomere shortening, suggesting that early adversity may involve systemic processes affecting multiple somatic tissues. The cord blood grouping was not significant. There were only two studies utilizing this source tissue; the magnitude of the effect was large (d = − 1.07), but the confidence intervals were wide. These preliminary results suggest that further investigations utilizing cord blood are warranted, as definitive conclusions cannot be drawn without additional data.
Study design affected the relationship between telomere length and early adversity, with cross-sectional and case-control studies showing highly significant effects. Prospective studies did not have a significant effect and there was substantial heterogeneity in this group (I 2 = 60%). Of the four studies in the prospective group, one examined newborns exposed to perinatal adversity, 68 one examined children 22 and two examined adult populations with early adversity and psychiatric disorders. 30, 64 The effect sizes ranged from 0.003 to − 1.73. The results of this meta-analysis suggest that differences in developmental timing of adversity exposure and comorbidities likely contributed to the heterogeneity. Further prospective studies are needed to clarify the relationship between early adversity and telomere length over time.
When examining the association between early adversity and telomere length by cigarette use, the Cohen's d decreased in magnitude with an increasing percentage of smokers in the study (P = 0.038). Older subject age was also associated with effects that were smaller in magnitude (P o 0.0001). These findings may be influenced by the fact that studies of young children were assumed not to include smokers, and our finding that adversity at an earlier developmental stage was associated with a larger effect on telomere length.
The limitations of this meta-analysis include the use of peerreviewed, trial-level published data to increase confidence in the validity of the data, which is common practice in meta-analyses, but constrains Cohen's d effect size calculations to data obtained from published studies. A pooled individual patient analysis approach could prove useful, especially for understanding moderator effects. Our analysis of developmental stage at adversity exposure is limited by the fact that many studies assessed adversity during large developmental timeframes rather than during discrete time periods. Most papers published were from developed nations; as such our ability to detect the longterm sequelae of poverty was limited due to the populations represented in the existing literature.
Telomere shortening may be a mechanism by which early adversity impacts disease risk. This may reflect underlying biological processes triggered by early life adversity, such as dysregulated stress signaling, altered metabolism and mitochondrial dysfunction, and increased inflammation and oxidative stress. Early adversity not only impacts children at an immediate, emotional and physical level, 76 but may have long-lasting health sequelae that are biologically based as well. These results highlight the importance of preventing, recognizing and intervening on multiple forms of adversity including abuse, poverty, and caregiver loss and neglect. Heterogeneity within these results suggests that there are likely factors impacting individual susceptibility to telomere shortening after early life adversity exposure. Prospective studies with rich measures of exposures, medical and psychiatric conditions, and targeted interventions will help determine the causality and reversibility of the observed association between early adversity and telomere length, as well as help identify factors that may determine susceptibility or protection against early life adversity-associated telomere shortening. Additionally, individual-level patient analyses of these moderators may add to our understanding. Research examining the biological mechanisms by which early life adversity is associated with telomere attrition should focus on causal links, developmental stage of exposure and interventions that may reverse these deleterious effects.
